Study of SGR-1505 in Mature B-Cell Neoplasms
Phase 1
52
about 3 years
18+
16 sites in AZ, DE, FL +10
What this study is about
This trial is testing a treatment called SGR-1505 for people with certain types of mature B-cell cancers. The goal is to see if the treatment is safe and how well it works, as well as find the highest dose that can be given safely.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Take SGR-1505
Participation Burden
What's physically and logistically required of participants.
Requires travel to a study site
How treatment is administered
Everyone gets the investigational treatment.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
Primary: Nature and number of incidences of dose limiting toxicity (DLT)., Nature, severity, and number of incidences of adverse events (AEs), serious AEs (SAEs), and AEs leading to treatment discontinuation.
Secondary: Disease Control Rate, Duration of Response (DOR), Objective Response Rate (ORR), SGR-1505 Area Under the Concentration Versus Time Curve (AUC), SGR-1505 Maximal Plasma Concentration (Cmax), SGR-1505 Time to Maximal Plasma Concentration (tmax)
Oncology